Revision [6594]

This is an old revision of GuangxuJin made by GuangxuJin on 2013-06-27 00:21:52.



Guangxu Jin Ph.D.

Chinese Name: 金光旭

Present Title & Affiliation

Primary Appointment

Research Associate, Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, TX

Office Address

The Methodist Hospital Research Institute
6565 Fannin ST
Houston, TX 77030
Office: +1 (713)441-7268
Cell: +1 (281)627-1455

Education & Training

Degree-Granting Education

2005.9 ~ 2008.7Academy of Mathematics & Systems Science, CAS, Ph.D., Operational Research
2002.9 ~ 2005.7Shenyang Normal University, M.S., Operational Research
1998.9 ~ 2002.7Shenyang Normal University, B.S., Applied Mathematics

Postgraduate Traning

2007.12 ~ 2008.10Exchange Student, The Methodist Hospital Research Institute & Weill Cornell Medical College
2008.10 ~ 2012.9Postdoctoral Fellow, The Methodist Hospital Research Institute & Weill Cornell Medical College

Professional Memberships

American Association Cancer Research
Associate Member, 2011.2 - present

Intelligent Systems for Molecular Biology
Member, 2012.4 - present

American Chemical Society
Member, 2012.2 - present

Research Interests


Selected Publications

Peer-Reviewed Original Research Articles

  1. Changhe Fu*, Guangxu Jin*, Junfeng Gao, Rui Zhu, Efren Ballesteros villagrana, Stephen T.C. Wong (2013)
    DrugMap Central (DMC), an on-line query and visualization tool to facilitate drug repositioning studies.
    Bioinformatics. Accepted. DOI:10.1093/bioinformatics/btt279 *Co-first author.
  2. Hong Zhao*, Guangxu Jin*, Kemi Cui , Ding Ren , Timothy Liu , Peikai Chen , Solomon Wong , Fuhai Li , Yubo Fan , Angel A. Rodriguez , Jenny C. Chang, Stephen T.C. Wong (2013)
    Downstream Signaling Modeling of Cancer Signaling Pathways Enables Systematic Drug Repositioning For Subtypes of Breast Cancer Metastases.
    Cancer Research, under revision. *Co-first author.
  3. Fuhai Li, Zheng Yin, Guangxu Jin, Hong Zhao, Stephen Wong (2013)
    Bioimage Informatics for Systems Pharmacology.
    PLoS Comput Biol 9, e1003043.
  4. Wang, L., Zhao, H., Cui, K., Yao, L., Ren, M., Hao, A., Smollen, P., Nie, F., Jin, G., Liu, Q. et al. (2012)
    Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
    Bioscience trends, 6, 192-200.
  5. Wang, L., Liu, Q., Zhao, H., Cui, K., Yao, L., Nie, F., Jin, G., Hao, A. and Wong, S.T. (2013)
    Differential effects of low- and high-dose GW2974, a dual epidermal growth factor receptor and HER2 kinase inhibitor, on glioblastoma multiforme invasion.
    Journal of neuroscience research, 91, 128-137.
  6. Fu, C., Deng, S., Jing, L., and Jin, G. (2012)
    Idenfication of Oncogenic Genes for Colon Adenocarcinoma from Genomics Data.
    IEEE systems biology, 6:263-266.
  7. Guangxu Jin, Changhe Fu, Hong Zhao, Kemi Cui, Jenny Chang, Stephen T.C. Wong
    A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy.
    Cancer Res, 72:33-44, 2012.
  8. Guangxu Jin, Hong Zhao, Xiaobo Zhou, Stephen T.C. Wong
    An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data.
    Bioinformatics, 27(13):i310-6, 2011.
  9. Zhao H, Cui K, Nie F, Wang L, Brandl MB, Jin G, Li F, Mao Y, Xue Z, Rodriguez A, et al.,
    The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
    Breast Cancer Res Treat. 2011
  10. Jin G, Cui K, Zhou X, Wong ST
    Unraveling the signal-transduction networks in cancer metastasis.
    IEEE Signal Proc Mag 26: 129-132, 2009.
  11. Jin G, Zhou X, Cui K, Zhang XS, Chen L, Wong ST
    A cross-platform method for identifying candidate network biomarkers for prostate cancer.
    IET Syst Biol 3(6), 505-512, 2009.
  12. Wang RS, Jin G, Zhang XS, Chen L